Why I believe it’s time to give up on buy-to-let and buy stocks instead

With returns from buy-to-let shrinking, Rupert Hargreaves looks at three other asset classes he thinks could produce better returns.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The investment case for buy-to-let property doesn’t look good right now. There are so many different headwinds facing the asset class, it’s hard to see how buy-to-let can continue to produce the high single-digit annual returns it has done for the past decade. Brexit uncertainty, rising interest rates, an uncertain outlook for UK property prices, higher stamp duty for buy-to-let properties, increasing regulation, and rent stagnation are just some of the factors that mean the outlook for landlords is now nowhere near as promising as it has been in the past.

With this being the case, I believe there are now better places to invest your money than buy-to-let. Equities are at the top of my list. 

Booming industry 

Take the e-commerce sector, for example. Over the past 12 months, we’ve heard plenty about the death of the UK high street, but the other side of this equation is the boom in online shopping. Demand for warehouse space has exploded, and so have the bottom lines of companies that specialise in buying and leasing out these properties. As more and more retail shifts online, it doesn’t look as if this trend is going to come to an end anytime soon.

The shifting sands in the retail sector is just one of the trends that look set to produce more profit for investors in the near term than buy-to-let investing.

Global trend 

The best performing stock in the FTSE 250 this year is Hikma Pharmaceuticals. Hikma is one of the world’s leading pharmaceutical businesses, specialising in the production of low-cost generic medicines.

As the world’s population continues to expand, the demand for affordable healthcare is only going to increase. And for companies like Hikma, the only way is up. 

Healthcare has always been a safe industry to invest in, and over the past decade, healthcare returns have far exceeded those from property. An index of the world’s largest healthcare companies has returned 15.1% per annum since 2008, compared to just 11.1% for a global property index.

Emerging growth 

Another theme that’s almost certain to produce buy-to-let-beating returns over the next few decades is emerging markets.

While politicians here in the UK are trying to cool the UK housing market, analysts believe emerging market growth will only accelerate for the foreseeable future. Regions such as Africa and India have desirable demographics, such as young populations with rapidly-improving skill sets, and low penetration of financial products. Technology has opened up these markets for Western companies, and they should continue to register impressive growth, no matter what happens here in the UK or across Europe. 

Investing in emerging markets is relatively easy today. All you need to do is buy a highly-diversified emerging market-focused ETF. This will give you instant exposure to thousands of companies across the developing world.

Conclusion 

So overall, I believe it’s time to give up on buy-to-let as returns from this asset class stagnate. I reckon investors would do much better putting their money in other key global investment themes, such as emerging markets, healthcare and e-commerce. 

Not only will these asset classes produce better returns, in my opinion, but they will also protect your portfolio from any Brexit fallout.

Rupert Hargreaves owns no share mentioned. The Motley Fool UK has recommended Hikma Pharmaceuticals. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »